Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Post by lscfaon Dec 14, 2016 8:40am
345 Views
Post# 25596933

Q4 on sedar.com

Q4 on sedar.com2016 cash eps = $0.25 (excludes amort of intangibles)......  
 
2016 cfps = $0.30 (cash flow from ops).......  
 
2017 guidance EBITDA $44 - $48 mil with 60% coming in 2nd half and includes $4 mil of $8 mil in plant savings => run rate at end of 2017 is $59 mil editda ($0.53/SH.)......


<< Previous
Bullboard Posts
Next >>